Rejected at 7:47 p.m. Oct, 31, 2023 ] by dollajas
Author: meechy1005
Related Note: 1461797775253 1
Rationale for change

The Sketchy NRTI video includes emtricitabine as a treatment for HBV infection.

Rejection reason

approved elsewhere, thanks!

Text Text
Extra
- Since most acute hepatitis B infections in adults are self-limited, antiviral therapy is not routinely indicated

- Nucleoside (NRTIs) and nucleotide (NtRTIs) reverse transcriptase inhibitors

- PEG-IFN is used for certain demographics (young patient with liver disease, HDV co-infection)
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid

Sketchy

Sketchy 2
Empty field
Sketchy Extra


Watch Hepatitis B Viral Basics & Infectious Diseases (Hepadnaviridae)



Watch NRTIs
Picmonic
Empty field
Pixorize


Physeo
Empty field
Bootcamp
Watch associated Bootcamp video - Viral Hepatitis

Watch associated Bootcamp video - DNA Viruses: Hepatitis B Virus: Diagnostics and Management
OME

Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#FirstAid::03_Microbiology::07_Antimicrobials::51_Hepatitis_C_therapy #AK_Step1_v12::^Other::^HighYield::2-RelativelyHighYield #PANCE::GI::hepatic_disorders #AK_Step1_v12::^Systems::GI::pharm #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::06_HIV_Antivirals::01_NRTIs #AK_Step1_v12::#Bootcamp::Microbiology::31_DNA_Viruses::20_Hepatitis_B_Virus_Diagnostics_and_Management #AK_Step1_v12::#Pixorize::04_Microbiology::03_Antivirals::06_NRTIs #AK_Step1_v12::#OME::PreClinical::Microbiology::Microbiology_3::Viruses::Antiviral_Medications #AK_Step1_v12::#SketchyPharm::07_Antimicrobials::08_Retired_Lessons::04_Ribavirin,_Sofosbuvir,_Simeprevir_[Retired_Video] !AK_UpdateTags::Step1decks::Zanki-Pharmacology #AK_Step1_v12::#SketchyMicro::03_Viruses::03_DNA::12_Hepatitis_B_Viral_Basics_&_Infectious_Diseases_(Hepadnaviridae) #AK_Step1_v12::#Bootcamp::Gastroenterology::06_Hepatic_Pathology::02_Viral_Hepatitis #AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#Physeo::09_Pharm::02_Antivirals::05_NRTIs #AK_Step1_v12::#AMBOSS::oia0s4 #AK_Step1_v12::#B&B::13_Infectious_Disease::06_Viruses::05_Viral_Hepatitis::Extra #AK_Step2_v12::#AMBOSS::fQ0kvf